Assessing the effectiveness of a psychoeducation program for caregivers of schizophrenia patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of a psychoeducation program called BREF on caregivers of patients with schizophrenia or first episode psychosis. It involves training health professionals to implement this program and assessing its effects on caregiver burden, patient outcomes, and mental health professionals' training. The study uses a multicentric stepped-wedge randomized control design, measuring outcomes at various intervals for caregivers, patients, and psychiatric departments. The goal is to integrate systematic psychoeducation into routine care for better health outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* people over 18yo
* first-degree relatives (parents, siblings, children) or spouse of the patient
* primary caregiver of a patient with schizophrenic disorders or first psychotic episode (DSM5)
* consenting to participate to the study

Exclusion Criteria:

* mental disorder on Axis I
* having already benefited from a family intervention such as psychoeducation
* caring for several people with severe psychiatric disorders
* receiving income for the caring activities
* being legally responsible of the patient
* having difficulty understanding fluent French
* illiterate

Where it's running

• Hopital Vinatier
  Bron, France Recruiting

Study contacts

• Principal investigator: Romain REY, MD, PhD — Ch Le Vinatier
• Study coordinator: Romain REY, MD, PhD
• Email: romain.rey@ch-le-vinatier.fr
• Phone: +33437915495

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Lumateperone to improve motivation in patients with schizophrenia and psychosis

  This study is testing if Lumateperone can help people with schizophrenia or schizoaffective disorders feel more motivated and less apathetic.

  Recruiting Phase 3 Louisiana State University Health Sciences Center Shreveport · Shreveport, Louisiana · NCT06482554

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• XEP527 in stable schizophrenia: safety and how it behaves in the body

  This small, early-stage study tests the safety and how XEP527 behaves in people with stable schizophrenia who are on a single antipsychotic.

  Recruiting Phase 1 Novartis · Bentonville, Arkansas · NCT07908680

• Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations

  This study tests whether theta-burst transcranial magnetic stimulation can lessen persistent auditory verbal hallucinations in adults with schizophrenia-spectrum or psychotic disorders who have not responded to antipsychotic meds.

  Recruiting Ciusss de L'Est de l'Île de Montréal · Montreal, Quebec · NCT07902518

• Quality of life and safety in quetiapine use for schizophrenia or bipolar disorder

  This study looks at how patients with schizophrenia or bipolar disorder feel and stay safe when treated with quetiapine alone or with other antipsychotics.

  Recruiting Bosnalijek D.D · Sarajevo · NCT07858565

• Neuronavigated rTMS for treatment-resistant auditory hallucinations

  We are testing whether personalized neuronavigated inhibitory rTMS can reduce persistent auditory verbal hallucinations in adults who don’t respond to medication.

  Recruiting Psychiatric University Hospital, Zurich · Zurich · NCT07856368

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.